Shearlink Capital Has Raised Splunk (SPLK) Stake By $3.07 Million; Private Advisor Group Has Raised Its Biogen (BIIB) Holding

January 14, 2018 - By Louis Casey

Shearlink Capital Llc increased Splunk Inc (SPLK) stake by 18.53% reported in 2017Q3 SEC filing. Shearlink Capital Llc acquired 46,582 shares as Splunk Inc (SPLK)’s stock rose 2.42%. The Shearlink Capital Llc holds 298,029 shares with $19.80M value, up from 251,447 last quarter. Splunk Inc now has $12.68 billion valuation. The stock increased 0.21% or $0.19 during the last trading session, reaching $89.64. About 1.41M shares traded. Splunk Inc. (NASDAQ:SPLK) has risen 30.53% since January 14, 2017 and is uptrending. It has outperformed by 13.83% the S&P500.

Private Advisor Group Llc increased Biogen Inc (BIIB) stake by 25.06% reported in 2017Q3 SEC filing. Private Advisor Group Llc acquired 1,368 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Private Advisor Group Llc holds 6,827 shares with $2.23 million value, up from 5,459 last quarter. Biogen Inc now has $71.05 billion valuation. The stock increased 0.86% or $2.88 during the last trading session, reaching $335.95. About 885,516 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since January 14, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Among 31 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Biogen Idec Inc. had 95 analyst reports since July 23, 2015 according to SRatingsIntel. On Thursday, March 16 the stock rating was downgraded by Leerink Swann to “Market Perform”. The firm has “Strong Buy” rating given on Thursday, December 29 by Raymond James. Cowen & Co maintained Biogen Inc. (NASDAQ:BIIB) on Tuesday, August 25 with “Buy” rating. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Monday, July 17 by BMO Capital Markets. As per Tuesday, September 6, the company rating was downgraded by Jefferies. The firm has “Neutral” rating by UBS given on Wednesday, July 26. The company was maintained on Thursday, June 1 by BMO Capital Markets. The stock of Biogen Inc. (NASDAQ:BIIB) has “Neutral” rating given on Monday, July 27 by Robert W. Baird. Goldman Sachs upgraded Biogen Inc. (NASDAQ:BIIB) on Wednesday, July 26 to “Buy” rating. The company was initiated on Wednesday, September 9 by Jefferies.

Since January 9, 2018, it had 0 buys, and 1 sale for $1.92 million activity. $1.92 million worth of Biogen Inc. (NASDAQ:BIIB) shares were sold by PANGIA ROBERT W.

Private Advisor Group Llc decreased Eaton Vance Flting Rate Inc (EFT) stake by 116,893 shares to 12,018 valued at $176,000 in 2017Q3. It also reduced Ventas Inc (NYSE:VTR) stake by 8,360 shares and now owns 22,382 shares. Maxim Integrated Prods Inc (NASDAQ:MXIM) was reduced too.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It is positive, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Retail Bank invested 0.06% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Millennium Management Lc has invested 0.09% in Biogen Inc. (NASDAQ:BIIB). Tiaa Cref Inv Ltd Limited Liability Company has invested 0.45% in Biogen Inc. (NASDAQ:BIIB). Parametric Associate Ltd Llc accumulated 743,537 shares. 890 are owned by Stearns Services Group. Willingdon Wealth Mngmt reported 130 shares stake. Victory Capital Incorporated accumulated 8,433 shares. Nbt Bancshares N A Ny owns 4,869 shares. Wright Investors Service Inc, Connecticut-based fund reported 3,817 shares. Jpmorgan Chase stated it has 2.48 million shares. Asset Management One has invested 0.27% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Fred Alger Mgmt Inc holds 7,792 shares or 0.01% of its portfolio. Adage Capital Prns Group Incorporated has invested 0.19% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Massachusetts Finance Serv Ma holds 1.79 million shares. Principal Finance holds 452,536 shares or 0.14% of its portfolio.

Investors sentiment increased to 1.41 in 2017 Q3. Its up 0.35, from 1.06 in 2017Q2. It is positive, as 33 investors sold SPLK shares while 81 reduced holdings. 53 funds opened positions while 108 raised stakes. 143.10 million shares or 3.45% more from 138.32 million shares in 2017Q2 were reported. Cibc Asset stated it has 5,741 shares or 0% of all its holdings. Adirondack Trust Communication has invested 0% in Splunk Inc. (NASDAQ:SPLK). 130 are owned by Ledyard Bank. Reilly Fincl Advisors Ltd Liability has 43 shares. Bamco has 0.02% invested in Splunk Inc. (NASDAQ:SPLK) for 54,844 shares. Castleark Management Limited Co invested 0.38% in Splunk Inc. (NASDAQ:SPLK). Efg Asset Mngmt (Americas) reported 0.2% of its portfolio in Splunk Inc. (NASDAQ:SPLK). Prudential Finance accumulated 7,120 shares or 0% of the stock. Perigon Wealth Mngmt Lc holds 0.58% or 26,907 shares. Gulf Intll Fincl Bank (Uk) Limited holds 41,779 shares or 0.04% of its portfolio. Virtu Financial Limited Co reported 27,914 shares. Sumitomo Mitsui Tru reported 594,980 shares. 7,039 are owned by Group Incorporated One Trading Limited Partnership. Patten Gru Inc owns 24,746 shares for 0.06% of their portfolio. Barclays Public Limited Company stated it has 43,827 shares or 0% of all its holdings.

Since August 14, 2017, it had 0 insider purchases, and 16 selling transactions for $33.06 million activity. The insider CONTE DAVID F sold 10,525 shares worth $694,980. 7,500 shares were sold by Campione Richard, worth $598,350 on Wednesday, December 13. 4,750 shares were sold by St. Ledger Susan, worth $380,665 on Wednesday, December 13. SULLIVAN GODFREY had sold 40,000 shares worth $2.54 million on Thursday, October 12. 4,851 shares were sold by STEIN LEONARD R, worth $390,684 on Sunday, December 10. 10,126 Splunk Inc. (NASDAQ:SPLK) shares with value of $810,586 were sold by Merritt Douglas. Neustaetter Thomas M sold $244,668 worth of stock or 3,614 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.